Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.

Autor: Nagel JH; Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands., Peeters JK, Smid M, Sieuwerts AM, Wasielewski M, de Weerd V, Trapman-Jansen AM, van den Ouweland A, Brüggenwirth H, van I Jcken WF, Klijn JG, van der Spek PJ, Foekens JA, Martens JW, Schutte M, Meijers-Heijboer H

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Apr; Vol. 132 (2), pp. 439-48. Date of Electronic Publication: 2011 May 26.